Optimal tumor sampling for immunostaining of biomarkers in breast carcinoma
Juliana Tolles(University of California, Los Angeles), Annette M. Molinaro(University of California, San Francisco)
Cited by 25
Related Papers
MGMT promoter methylation level in newly diagnosed low-grade glioma is a predictor of hypermutation at recurrence
|Neuro-Oncology|2020|96
Prospective genomically guided identification of “early/evolving” and “undersampled” IDH-wildtype glioblastoma leads to improved clinical outcomes
|Neuro-Oncology|2022|31